Delivery Order SPE2DB22D3301-SPE2DB25FX4LG

Award Date 10/25/24
Potential Completion Date 10/28/24
Potential Value $8.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,413.10, is for the delivery of Advair HFA 115-21 MCG Inhaler (12GM) to support military healthcare programs. The contract has a fixed-price delivery order structure and an ultimate completion date of January 9, 2024. This award is part of a larger Indefinite Delivery...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $14,618.85 contract is for the delivery of Advair HFA 230-21 MCG Inhaler, which is a prescription medication. The delivery order is a firm-fixed-price contract with a completion date of September 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,043.10 firm fixed-price contract is for the delivery of Advair HFA 45-21 MCG Inhaler 12GM, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00. The IDC provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 MCG Inhaler 12GM. The award, valued at $6,563.68, is a firm fixed-price contract with an ultimate completion date of August 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,589.44 firm fixed-price contract is for the supply of the pharmaceutical product Advair HFA 230-21 MCG Inhaler 12GM. The contract has an ultimate completion date of July 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,266.84, is for the delivery of Advair HFA 115-21 MCG inhalers. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,474.48 firm fixed price contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a respiratory medication. The award date is January 9, 2024, with an ultimate completion date of January 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for $1,330.53 and covers the delivery of Advair HFA 45-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has an ultimate completion date of March 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG Inhaler. The $3,020.60 firm-fixed-price contract has an ultimate completion date of August 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,805.22, is for the provision of Advair HFA 230-21 MCG inhalers, a brand-name respiratory medication. The contract is a firm-fixed-price delivery order with a completion date of February 28, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX4LG
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a major pharmaceutical distributor, for the supply of an Advair HFA 115-21 mcg inhaler product. The $8,933.10 firm fixed-price contract has an ultimate completion date of October 28, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition. This delivery order is focused on the provision of a specific prescription medication to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 1/24/25, 9:26 AM